Avacopan Terminated Phase 2 Trials for Atypical Hemolytic Uremic Syndrome (aHUS) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02464891Complement Inhibition in aHUS Dialysis Patients